drugset / Trial / NCT02041767

Assessment of Prostatic Tissue Concentration of Ertapenem After a Pre-operative Administration

NCT02041767

Non-randomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to demonstrate the prostatic diffusion in significant concentration of ertapenem achieved after a pre-operative single administration.

Timeline

Start
2013-12
Primary completion
2015-01
Completion
2015-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ertapenem Small molecule 1 g Intravenous